WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES ADDEX THERAPEUTICS LTDWarrant Agreement • July 26th, 2022 • Addex Therapeutics Ltd. • Pharmaceutical preparations
Contract Type FiledJuly 26th, 2022 Company IndustryTHIS WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (this “Warrant”) certifies that, for value received,_________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ______________ (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _______________ (the “Termination Date”), but not thereafter, to subscribe for and purchase from Addex Therapeutics Ltd, a Swiss limited company established and existing under the laws of Switzerland (the “Company”), up to _________ Ordinary Shares, par value CHF 1.00 per share (the “Warrant Shares”), represented by _________ ADSs (such ADSs issuable upon exercise of this Warrant, the “Warrant ADSs”), as subject to adjustment hereunder. The purchase price of one Warrant ADS shall be equal to the Exercise Price, as defined in Section 2(b)
PRE-FUNDED WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES ADDEX THERAPEUTICS LTDSecurity Agreement • July 26th, 2022 • Addex Therapeutics Ltd. • Pharmaceutical preparations
Contract Type FiledJuly 26th, 2022 Company IndustryTHIS PRE-FUNDED WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (this “Warrant”) certifies that, for value received,________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _____________ (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”), but not thereafter, to subscribe for and purchase from Addex Therapeutics Ltd, a Swiss limited company established and existing under the laws of Switzerland (the “Company”), up to __________________ Ordinary Shares, par value CHF 1.00 per share (the “Warrant Shares”), represented by _________________ ADSs (such ADSs issuable upon exercise of this Warrant, the “Warrant ADSs”), as subject to adjustment hereunder. The purchase price of one Warrant ADS shall be equal to the Exercise Price, as defined in Section 2(b)
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 26th, 2022 • Addex Therapeutics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJuly 26th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 22, 2022, between Addex Therapeutics Ltd, a société anonyme organized under the laws of Switzerland (the “Company”), and the purchaser identified on the signature pages hereto (the “Purchaser”).
AMENDMENT NO .1 TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 26th, 2022 • Addex Therapeutics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJuly 26th, 2022 Company Industry JurisdictionThis AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT (this “Amendment”) is entered into effective July 22, 2022 by and between Addex Therapeutics Ltd. a société anonyme organized under the laws of Switzerland (the “Company”) and Armistice Capital Master Fund Ltd. (“Purchaser”). Capitalized terms used but not defined herein have the meanings given them in the Agreement (as defined below).